PILL

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Down$14.10
$-0.40
(-2.76%)
As of 12:00:00 AM EDT | 10/18/19  |  Market Closed

PILL Trading Data

Open

$14.47

Low Price

$13.65

High Price

$14.55

Previous Last Price

$14.5

Bid Size

$0 X 0

Ask Size

$0 X 0

PILL Portfolio Data

AUM

$15,277,500

Shares

1,050

PE Ratio

18.04

Price / Book Ratio

2.71

Expense Ratio

0.99

Net Asset Value

$14.55

Volume

Volume

51,300

Avg. Volume (YDT)

24,295

Dollar Volume

$0

Weekly Avg. Volume

146,540

Monthly Avg. Volume

49,750

Quarterly Avg. Volume

32,891

PILL Fund Description

The Direxion Daily Pharmaceutical and Medical Bull 3X Shares seek daily investment results, before fees and expenses of 300% of the performance of the Dynamic Pharmaceutical Intellidex Index.

PILL Chart

PILL Summary

Fund Family

Direxion Investments

Tracks This Index

Direxion Daily Pharmaceutical & Medical Bull 3X Shares

Inception Date

2017-11-15

Asset Class

Equity

Asset Class Size

PILL Classification

Region (General)

North America

Region (Specific)

US

Sector

Health Care

Equity Index

Leveraged Family

PILL Technicals

Alpha

0

Beta

2.97

Leverage

Triple-Long

Standard Deviation

6.27

PILL Dividends

Dividend Date

2019-09-24

Latest Dividend

0.015

Annual Dividend

0.19

Annual Dividend Rate

0.19

Annual Dividend Yield

1.33

PILL Performance

YTD Return

-33.74%

1 Year Return

-54.86%

3 Year Return

0%

5 Year Return

0%

10 Year Return

-46.44%

PILL Related Articles

4 Hot Pharmaceutical ETFs

4 Hot Pharmaceutical ETFs

Pharmaceutical ETFs invest in stocks of companies that are involved in the research, development, manufacture, sale or distribution of pharmaceuticals…

A Potent Pharmaceuticals ETF

A Potent Pharmaceuticals ETF

Healthcare ETFs have been displaying positive momentum. Traders looking to bolster that healthcare momentum profile can consider leveraged ETFs, such…

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.